RSV Vaccination (Maternal Immunization) Becomes Routine: Strengthening Information Provision for Pregnant Women
NQ Score
80/100
N1 Content Completeness
9
AI Summary (NQ-processed)
NPO Himawari no Kai announced enhanced efforts to promote the RSV vaccine (maternal immunization), which became a routine, publicly funded vaccination on April 1, 2026. Partnering with the Japan Midwives Association, they aim to educate pregnant women directly.
AI Analysis
Frequently Asked Questions
- Q: Who is eligible for the regular RS virus vaccine?
- A: Women who are pregnant between 28 weeks 0 days and 36 weeks 6 days are eligible.
- Q: Is there a cost for the vaccination?
- A: Since it is designated as a regular vaccination, it is covered by public funds and can be received without any out-of-pocket cost.
- Q: Why is it necessary for pregnant women to get vaccinated?
- A: To prevent severe RS virus in newborn infants by transferring antibodies through the placenta via maternal immunity.